BRPI0408882A - composições contendo lactulose para tratamento de infecções por rotavìrus - Google Patents
composições contendo lactulose para tratamento de infecções por rotavìrusInfo
- Publication number
- BRPI0408882A BRPI0408882A BRPI0408882-4A BRPI0408882A BRPI0408882A BR PI0408882 A BRPI0408882 A BR PI0408882A BR PI0408882 A BRPI0408882 A BR PI0408882A BR PI0408882 A BRPI0408882 A BR PI0408882A
- Authority
- BR
- Brazil
- Prior art keywords
- lactulose
- rotavirus infections
- containing compositions
- treating rotavirus
- infections
- Prior art date
Links
- 206010067470 Rotavirus infection Diseases 0.000 title abstract 3
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 title abstract 3
- 229960000511 lactulose Drugs 0.000 title abstract 3
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pediatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
"COMPOSIçõES CONTENDO LACTULOSE PARA TRATAMENTO DE INFECçõES POR ROTAVìRUS". Apresenta-se um processo para inibir infecções por Rotavirus por administração de uma quantidade eficaz de lactulose. A lactulose pode ser administrada isoladamente ou em combinação com outros suplementos nutricionais, como vitaminas, ou como parte de um produto nutricional, como uma fórmula para bebês.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/401,390 US20040191295A1 (en) | 2003-03-28 | 2003-03-28 | Composition and method for viral inhibition |
PCT/US2004/008356 WO2004093885A1 (en) | 2003-03-28 | 2004-03-19 | Compositions containing lactulose for treating potavirus infections |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408882A true BRPI0408882A (pt) | 2006-04-11 |
Family
ID=32989437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408882-4A BRPI0408882A (pt) | 2003-03-28 | 2004-03-19 | composições contendo lactulose para tratamento de infecções por rotavìrus |
Country Status (13)
Country | Link |
---|---|
US (3) | US20040191295A1 (pt) |
EP (1) | EP1613331A1 (pt) |
KR (1) | KR20060002886A (pt) |
CN (1) | CN1795000A (pt) |
AR (1) | AR043937A1 (pt) |
BR (1) | BRPI0408882A (pt) |
CA (1) | CA2520647A1 (pt) |
CL (1) | CL2004000652A1 (pt) |
MX (1) | MXPA05010274A (pt) |
NO (1) | NO20055010L (pt) |
RU (1) | RU2005133224A (pt) |
TW (1) | TW200503735A (pt) |
WO (1) | WO2004093885A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1673987A1 (en) * | 2004-12-23 | 2006-06-28 | N.V. Nutricia | Temporally meal menu for infants |
US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
US8287931B2 (en) | 2005-06-30 | 2012-10-16 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
JP2009523175A (ja) * | 2006-01-10 | 2009-06-18 | パイペックス,インコーポレイテッド | 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法 |
US8986769B2 (en) * | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
US8425955B2 (en) | 2009-02-12 | 2013-04-23 | Mead Johnson Nutrition Company | Nutritional composition with prebiotic component |
US8293264B2 (en) * | 2009-05-11 | 2012-10-23 | Mead Johnson Nutrition Company | Nutritional composition to promote healthy development and growth |
PL2520177T5 (pl) * | 2009-12-29 | 2020-08-10 | Société des Produits Nestlé S.A. | Kompozycje odżywcze obejmujące płatki owocowe zawierające kwas dokozaheksaenowy |
WO2011093907A1 (en) * | 2010-02-01 | 2011-08-04 | Corn Products International, Inc. | High-purity galactooligosaccharides and uses thereof |
CN101843893B (zh) * | 2010-05-21 | 2012-02-01 | 中国人民解放军第三军医大学 | 环孢素a在制备抗轮状病毒药物中的应用 |
FR2961378A1 (fr) * | 2010-06-22 | 2011-12-23 | Solvay | Effet prebiotique d'oligosaccharides |
WO2012092153A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection |
NZ613180A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
WO2012092157A2 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
ES2667393T3 (es) | 2010-12-31 | 2018-05-10 | Abbott Laboratories | Oligosacáridos de leche humana para modular inflamación |
ES2968084T3 (es) * | 2017-04-28 | 2024-05-07 | Fresenius Kabi Austria Gmbh | Composiciones que comprenden lactulosa para mantener o mejorar la salud intestinal en seres humanos |
DE102019003442A1 (de) | 2019-05-15 | 2020-11-19 | Ilma biochem GmbH | Verwendung von niedermolekularen glykosidisch gebundenen endständigen Galactosiden und Fucosiden zur Bindung von als Galectin wirkenden Toxinen im Rahmen der Behandlung von Vergiftungen, insbesondere bei Vergiftungen mit Ricin |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3272705A (en) * | 1963-06-13 | 1966-09-13 | Philips Corp | Laxative composition and method of using same |
JPS4944331B1 (pt) * | 1971-05-31 | 1974-11-27 | ||
BE890753R (nl) * | 1981-10-16 | 1982-04-16 | Denecker Jan | Therapeutische compositie voor het behandelen van dieren, namelijk duiven |
JPS62138147A (ja) * | 1985-12-12 | 1987-06-20 | Snow Brand Milk Prod Co Ltd | ガラクトオリゴ糖類配合飼料 |
US4987124A (en) * | 1987-10-13 | 1991-01-22 | Coors Biotech, Inc. | Method for inhibiting the growth of salmonella |
US5439893A (en) * | 1993-05-26 | 1995-08-08 | University Of Montana | Methods for the treatment and prevention of diarrhea |
US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
US5658893A (en) * | 1995-03-29 | 1997-08-19 | Abbott Laboratories | Method for inhibition of rotavirus infection with carrageenan |
US5736533A (en) * | 1995-06-07 | 1998-04-07 | Neose Technologies, Inc. | Bacterial inhibition with an oligosaccharide compound |
US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
ES2123903T5 (es) * | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
RU2157639C1 (ru) * | 1999-06-22 | 2000-10-20 | Московский государственный университет прикладной биотехнологии | Способ производства кисломолочного продукта |
RU2189753C1 (ru) * | 2001-04-09 | 2002-09-27 | Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН | Стерилизованный молочный продукт для детского питания с рождения до пяти месяцев |
RU2187229C1 (ru) * | 2001-04-09 | 2002-08-20 | Государственное научное учреждение Научно-исследовательский институт детского питания РАСХН | Кисломолочный продукт для детского питания с рождения до пяти месяцев жизни |
RU2196432C1 (ru) * | 2001-06-29 | 2003-01-20 | Государственное научное учреждение Научно-исследовательский институт детского питания РАСХ | Композиция для приготовления кисломолочного продукта геродиетического питания |
-
2003
- 2003-03-28 US US10/401,390 patent/US20040191295A1/en not_active Abandoned
-
2004
- 2004-03-19 KR KR1020057018327A patent/KR20060002886A/ko not_active Application Discontinuation
- 2004-03-19 CN CNA2004800143298A patent/CN1795000A/zh active Pending
- 2004-03-19 CA CA002520647A patent/CA2520647A1/en not_active Abandoned
- 2004-03-19 EP EP04759667A patent/EP1613331A1/en not_active Withdrawn
- 2004-03-19 MX MXPA05010274A patent/MXPA05010274A/es not_active Application Discontinuation
- 2004-03-19 WO PCT/US2004/008356 patent/WO2004093885A1/en not_active Application Discontinuation
- 2004-03-19 BR BRPI0408882-4A patent/BRPI0408882A/pt not_active Application Discontinuation
- 2004-03-19 RU RU2005133224/15A patent/RU2005133224A/ru not_active Application Discontinuation
- 2004-03-24 TW TW093107946A patent/TW200503735A/zh unknown
- 2004-03-26 AR ARP040101018A patent/AR043937A1/es unknown
- 2004-03-26 CL CL200400652A patent/CL2004000652A1/es unknown
- 2004-07-08 US US10/886,760 patent/US20050014717A1/en not_active Abandoned
-
2005
- 2005-05-26 US US11/138,585 patent/US20050276838A1/en not_active Abandoned
- 2005-10-27 NO NO20055010A patent/NO20055010L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20055010L (no) | 2005-12-27 |
EP1613331A1 (en) | 2006-01-11 |
MXPA05010274A (es) | 2005-11-17 |
WO2004093885A9 (en) | 2006-06-29 |
CN1795000A (zh) | 2006-06-28 |
RU2005133224A (ru) | 2006-02-27 |
AR043937A1 (es) | 2005-08-17 |
US20050014717A1 (en) | 2005-01-20 |
CA2520647A1 (en) | 2004-11-04 |
CL2004000652A1 (es) | 2005-05-27 |
US20050276838A1 (en) | 2005-12-15 |
WO2004093885A1 (en) | 2004-11-04 |
NO20055010D0 (no) | 2005-10-27 |
KR20060002886A (ko) | 2006-01-09 |
US20040191295A1 (en) | 2004-09-30 |
TW200503735A (en) | 2005-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408882A (pt) | composições contendo lactulose para tratamento de infecções por rotavìrus | |
BR0116201A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende o composto, utilização do composto, processo para o tratamento e profilaxia de distúrbios e para o tratamento de obesidade | |
BR0307291A (pt) | Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; método para o tratamento e profilaxia de distúrbios diversos e de obesidade em um humano | |
BR0116605A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono | |
BR0209957A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
BR0112918A (pt) | Composto, utilização do mesmo, processo de tratamento de distúrbios, processo para a preparação de composto, composição farmacêutica que compreende esse composto, processo para preparar uma composição e processo de tratamento de obesidade em um ser humano | |
BRPI0415953A (pt) | formulação de dosagem de liberação controlada oral, método de tratamento de um distúrbio, conjunto de formas de dosagem de liberação controlada e método para administração da formulação | |
BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
UA94901C2 (ru) | Антибактериальные производные пиперидина | |
BRPI0210941B8 (pt) | produto farmacêutico contendo combinações de oxazolidinonas substituídas, seu uso, seu processo de produção, e medicamento | |
GEP20032925B (en) | Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake | |
BR0212929A (pt) | Compostos, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de compostos, e método para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, disfunção renal, distúrbios alimentares e obesidade | |
BRPI0606393A2 (pt) | prevenção de doenças trombóticas com compostos ativos de vitamina d ou similares do mesmo | |
EA200100623A1 (ru) | Кетолидные антибиотики | |
BRPI0411906A (pt) | compostos, processo para a sua preparação, composições farmacêuticas que compreendem os mesmos, método para tratar ou prevenir uma enfermidade mediada pela ativação da enzima de sintase de glicogênio, e utilização dos compostos | |
GB9510037D0 (en) | Improvements in or relating to organic compounds | |
BR0315801A (pt) | Compostos piridopirimidinona, eu processo de preparação e as composições farmacêuticas que os contêm | |
BR0115045A (pt) | Compostos, processo para sua preparação, composição farmacêutica que compreende os mesmos, sua utilização, processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
AU1185801A (en) | Novel compounds | |
BR0314261A (pt) | Compostos, processo de preparação de um composto, composição farmacêutica que compreende o mesmo, utilização de um composto, método para tratamento e/ou profilaxia de enfermidades e utilização e/ou método de tratamento | |
BRPI0801239A2 (pt) | uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase | |
MXPA04007183A (es) | Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2. | |
BR0308837A (pt) | Composto, composição, método e medicamento para o tratamento de infecções bacterianas, psorìase ou artrite em mamìferos, método e medicamento para o tratamento de toxicidade devido a quimioterapia em um paciente, composição farmacêutica, processo para a preparação de um composto e processo para a conversão dos compostos da fórmula (i) em compostos adicionais da fórmula (i) | |
BRPI0410189A (pt) | uso de derivados de sulfonamida para a manufatura de um medicamento para a profilaxia e/ou tratamento de distúrbios relacionados com a ingestão de alimentos | |
BR0308576A (pt) | Compostos: composições farmacêuticas para administração em um mamìfero e métodos para inibir a enzima citocroma p450rai em um mamìfero |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |